Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07301177 · ClinicalTrials.gov registry record · NA
DoD AtMS for Posttraumatic Peripheral Neuropathic Pain
A NA study of Peripheral Neuropathy and Posttraumatic Peripheral Neuropathic Pain, sponsored by Veterans Medical Research Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT07301177: Recruiting NA study of Peripheral Neuropathy and Posttraumatic Peripheral Neuropathic Pain, sponsored by Veterans Medical Research Foundation.
NCT07301177 is a NA study of Peripheral Neuropathy and Posttraumatic Peripheral Neuropathic Pain that is actively recruiting participants, run by Veterans Medical Research Foundation. The registered enrollment target is 180 participants, above the 74-participant average among 27 other Peripheral Neuropathy trials with a reported enrollment target (143% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07301177, a NA study of Peripheral Neuropathy and Posttraumatic Peripheral Neuropathic Pain, is actively recruiting participants, sponsored by Veterans Medical Research Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if adaptative transcutaneous magnetic stimulation (AtMS) works to reduce pain caused by post-traumatic peripheral neuropathic pain (PTP-NP) within Veterans and/or active duty military personnel. It will also learn about the safety of AtMS. The main questions it aims to answer are: 1. What are the effects of adaptative tMS (AtMS) in alleviating patients' PTP-NP compared to fixed tMS (FtMS) and Sham-tMS? 2. What are the effects of AtMS in improving functions in patients suffering from PTP-NP compared to FtMS and Sham-tMS? 3. What are the effects of AtMS in improving mood in patients suffering from PTP NP compared FtMS and Sham-tMS? Researchers will compare AtMS, FtMS and Sham-tMS to see if AtMS is the best form of tMS in treating PTP-NP. Participants will undergo the following: 1. Receive a total of 8 AtMS, FtMS, or Sham-tMS treatments over 16 weeks. 2. Visit the clinic a total of 12 times for assessments, check ups, and treatments. 3. Keep a daily diary of their PTP-NP intensity, sleep interference, and pain medications used.
Primary Outcome
0 is equivalent to no neuropathic pain and 10 indicates the worst possible neuropathic pain
Conditions Studied
Interventions
- DEVICE Transcutaneous magnetic stimulation (tMS)
- DEVICE Sham transcutaneous magnetic stimulation (Sham-tMS)
- DEVICE Patient Machine Interface (PMI)
Study Locations (1)
California
- Veterans Medical Center - San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-04-30 |
| Est. Completion | 2029-03 |
| Phase | NA |
What NCT07301177 shows while recruiting
NCT07301177 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 74-participant average among 27 other Peripheral Neuropathy trials with a reported enrollment target (143% higher).
The record links to 4 conditions, with Peripheral Neuropathy appearing as the primary indexed condition, and to 3 interventions - of which Transcutaneous magnetic stimulation (tMS) is the first listed.
NCT07301177 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07301177 about?
NCT07301177 is a clinical study titled "DoD AtMS for Posttraumatic Peripheral Neuropathic Pain". The goal of this clinical trial is to learn if adaptative transcutaneous magnetic stimulation (AtMS) works to reduce pain caused by post-traumatic peripheral neuropathic pain (PTP-NP) within Veterans and/or active duty military personnel. It will also learn about the safety of AtMS. The main questio...
What is the current status of trial NCT07301177?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-04-30. Estimated completion is 2029-03.
What conditions does trial NCT07301177 study?
This clinical trial studies the following conditions: Peripheral Neuropathy, Posttraumatic Peripheral Neuropathic Pain, Peripheral Neuropathy Due to Surgical Trauma, Peripheral Neuropathy Due to Physical Trauma.
What interventions are being tested in trial NCT07301177?
The interventions under investigation include: Transcutaneous magnetic stimulation (tMS) (DEVICE), Sham transcutaneous magnetic stimulation (Sham-tMS) (DEVICE), Patient Machine Interface (PMI) (DEVICE).
Who is sponsoring clinical trial NCT07301177?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07301177 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07301177's enrollment target sits among peer trials
180 5th of 27 higher than 23 of 27 other Peripheral Neuropathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Neuropathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy
RECRUITING · NA
-
Reliability of Force Measurement Within the Carbon Fiber Orthosis Proximal Cuff
RECRUITING · NA
-
Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies
ACTIVE NOT RECRUITING · NA
-
Clinical Study of a Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (COMFORT 2)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI